The role of Purα in neuronal development, the relationship between Purα and epilepsy in the current researches

Open Access

Issue		BIO Web Conf. Volume 8, 2017 2016 International Conference on Medicine Sciences and Bioengineering (ICMSB2016)


Article Number		01056
Number of page(s)		7
Section		Session I: Medicine
DOI		https://doi.org/10.1051/bioconf/20170801056
Published online		11 January 2017

S.M. Barr, E.M Johnson. Journal of cellular biochemistry. 2001; 81(4):621–38. [CrossRef] [PubMed] [Google Scholar]
A.D. Bergemann, EM Johnson. Molecular and cellular biology. 1992; 12(3):1257–65. [CrossRef] [PubMed] [Google Scholar]
A.D. Bergemann, Z.W. Ma, E.M. Johnson. Molecular and cellular biology. 1992; 12(12): 5673–82. [CrossRef] [PubMed] [Google Scholar]
G.L. Gallia, E.M. Johnson, and K. Khalili. Nucleic Acids Res. 2000; 28(17):3197–205. [CrossRef] [PubMed] [Google Scholar]
E.M. Johnson. Anticancer Res. 2003; 23(3A):2093–100. [PubMed] [Google Scholar]
E.M Johnson, Y. Kinoshita, D.B. Weinreb, et al. J Neurosci Res. 2006; 83(6):929–43. [CrossRef] [PubMed] [Google Scholar]
D.W. Stacey, M. Hitomi, M. Kanovsky, et al. Oncogene. 1999; 18(29):4254–61. [CrossRef] [PubMed] [Google Scholar]
N. Darbinian, G.L. Gallia, J. King, et al. J Cell Physiol. 2001; 189(3):334–40. [CrossRef] [PubMed] [Google Scholar]
K. Lezon-Geyda, V. Najfeld, E.M. Johnson. Leukemia. 2001; 15(6):954–62. [CrossRef] [PubMed] [Google Scholar]
H. Wang, M.K. White, R. Kaminski, et al. Anticancer research. 2008; 28(3A):1441–7. [PubMed] [Google Scholar]
H. Wang, M. Wang, K. Reiss, et al. Cancer biology & therapy. 2007; 6(4):596–602. [CrossRef] [PubMed] [Google Scholar]
S. Haas, J. Gordon, K. Khalili. Molecular and cellular biology. 1993; 13(5):3103–12. [CrossRef] [PubMed] [Google Scholar]
A. Tretiakova, G.L. Gallia, N. Shcherbik, et al. The Journal of biological chemistry. 1998; 273(35):22241–7. [Google Scholar]
K. Khalili, L. Del Valle, V. Muralidharan, et al. Mol Cell Biol. 2003; 23(19):6857–75. [Google Scholar]
J.G. Daigle, K. Krishnamurthy, N. Ramesh, et al. Acta Neuropathol. 2016; 131(4):605–20. [CrossRef] [PubMed] [Google Scholar]
P. Jin, R. Duan, A. Qurashi, et al. Neuron. 2007; 55(4):556–64. [CrossRef] [PubMed] [Google Scholar]
R.J. Hagerman, M. Leehey, W. Heinrichs, et al. Neurology. 2001; 57(1):127–30. [CrossRef] [PubMed] [Google Scholar]
S. Jacquemont, R.J. Hagerman, M. Leehey, et al. American journal of human genetics. 2003; 72(4):869–78. [CrossRef] [PubMed] [Google Scholar]
S.R. Lalani, J. Zhang, C.P. Schaaf, et al. American journal of human genetics. 2014; 95(5):579–83. [CrossRef] [PubMed] [Google Scholar]
D. Hunt, R.J. Leventer, C. Simons, et al. Journal of medical genetics. 2014; 51(12):806–13. [Google Scholar]
E.M. Johnson, D.C. Daniel, J. Gordon. Journal of cellular physiology. 2013; 228(5):930–7. [CrossRef] [PubMed] [Google Scholar]
M.K. White, E.M. Johnson, K. Khalili. Cell Cycle. 2009; 8(3):1–7. [PubMed] [Google Scholar]
S. Haas, P. Thatikunta, A. Steplewski, et al. J Cell Biol. 1995; 130(5):1171–9. [CrossRef] [PubMed] [Google Scholar]
Z.W. Ma, A.D. Bergemann, E.M. Johnson. Gene. 1994; 149(2):311–4. [Google Scholar]
H. Liu, E.M. Johnson. Nucleic Acids Res. 2002; 30(11):2417–26. [CrossRef] [PubMed] [Google Scholar]
N. Darbinian, G.L. Gallia, K. Khalili. J Cell Biochem. 2001; 80(4):589–95. [CrossRef] [PubMed] [Google Scholar]
T. Kong, M. Scully, C.S. Shelley, et al. J Immunol. 2007; 179(3):1934–41. [PubMed] [Google Scholar]
S. Hokkanen, H.M. Feldmann, H. Ding, et al. Hum Mol Genet. 2012; 21(3):473–84. [CrossRef] [PubMed] [Google Scholar]
D. Hunt, R.J. Leventer, C. Simons, et al. J Med Genet. 2014; 51(12):806–13. [CrossRef] [PubMed] [Google Scholar]
K. Shimojima, B. Isidor, C. Le Caignec, et al. American journal of medical genetics Part A. 2011; 155A (4):732–6. [CrossRef] [PubMed] [Google Scholar]
C. Mareni, B.R. Migeon. American journal of human genetics. 1981; 33(5):752–61. [PubMed] [Google Scholar]
P.J. Hagerman, R.J. Hagerman. Mental retardation and developmental disabilities research reviews. 2004; 10(1):25–30. [CrossRef] [PubMed] [Google Scholar]
R.J. Hagerman, B.R. Leavitt, F. Farzin, et al. American journal of human genetics. 2004; 74(5):1051–6. [CrossRef] [PubMed] [Google Scholar]
R.J. Hagerman, M.Y. Ono, P.J. Hagerman. Current opinion in psychiatry. 2005; 18(5):490–6. [CrossRef] [PubMed] [Google Scholar]
C.M. Greco, R.J. Hagerman, F. Tassone, et al. Brain: a journal of neurology. 2002; 125(Pt 8):1760–71. [CrossRef] [Google Scholar]
H. Tan, A. Qurashi, M. Poidevin, et al. Human molecular genetics. 2012; 21(1):57–65. [CrossRef] [PubMed] [Google Scholar]
A. Qurashi, W. Li, J.Y. Zhou, et al. PLoS genetics. 2011; 7(6):e1002102. [Google Scholar]
S.T. Warren, and S. L. Sherman, (2001). The fragile X syndrome. In The Metabolic & Molecular Bases of Inherited Disease, C.R. Scriver, A.L. Beaudet, D. Valle, B. Childs, K.W. Kinzler, and B. Vogelstein, eds. (New York: McGraw-Hill Companies), pp. 1257–1290. [Google Scholar]
S. Sherman, (2002). Epidemiology. In Fragile X Syndrome: Diagnosis, Treatment and Research, R.J. Hagerman, ed. (Baltimore, MD: The Johns Hopkins University Press), pp. 136–168. [Google Scholar]
J. Chai, Y. Li, H. Wang, and J. Cui, Archives of medicine, 2015, Vol. 7 No. 4:5. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.